Table 1.
Patient characteristics
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Age† (year) | 69 | 74 | 57 | 45 | 74 | 63 | 76 | 68 | 73 | 71 |
| Gender (M/F) | M | M | F | M | M | F | F | M | F | F |
| Primary | Lung | Pancreas | Ileum | Ileum | Unknown | MTC* | Ileum | Pancreas | Unknown | Ileum |
| Grade | 2 | 1 | 1 | 2 | 1 | NA | 2 | 1 | 1 | 1 |
| MIB-1 | 3-20% | 2% | 1% | 1% | 1% | NA | 5% | 2% | 1% | 2% |
| Ki-67 | NA | 2-5% | 3% | 2% | 0 | NA | 5% | 0% | 0% | 1% |
| Resection primary | Y | N | Y | Y | N | Y | N | N | Y | Y |
| Liver embolization | N | Y | Y | Y | N | N | N | N | N | N |
| SSA therapy | Y | Y | Y | Y | Y | N | N | Y | Y | Y |
| Chemo/targeted therapy | N | N | N | N | N | N | N | Y | N | N |
| Metastatic sides | Liver, LN, bone, other | Liver, LN, bone | Liver, LN, bone | Liver, other | Liver, LN, bone, other | LN | Liver, LN, bone, other | Liver, LN, other | Liver, LN, bone, other | Liver, LN, bone, other |
| Tumour lesions included | None |
Liver: 3 Other: 1 |
Liver: 2 Other: 1 |
Liver: 2 |
Liver: 2 Other: 2 |
Other: 1 |
Liver: 4 Other: 1 |
Liver: 5 Other: 1 |
Liver: 1 Other: 1 |
Liver: 2 |
| Administered activity (MBq) | 7131 | 7253 | 7176 | 7271 | 7188 | 7212 | 7613 | 7476 | 7338 | 7373 |
*Medullar thyroid carcinoma
LN lymph nodes; NA not available; SSA therapy somatostatin analogue use during PRRT treatment
*†Age at start PRRT